# FDA Inspection 1197431 - Marek Smilowski - January 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/marek-smilowski/0ea6a6f6-f1ca-486c-8e36-643b05ed527b
Source feed: FDA_Inspections

> FDA Inspection 1197431 for Marek Smilowski on January 12, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197431
- Company Name: Marek Smilowski
- Inspection Date: 2023-01-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1309212 - 2026-03-06](https://www.keypedia.com/records/fda_inspections/marek-smilowski/7dc8b7ad-a60b-404f-983f-b93786f449c5)
- [FDA Inspection 1309212 - 2026-03-06](https://www.keypedia.com/records/fda_inspections/marek-smilowski/205bacbc-4b5d-4749-bb4d-656df4aa6db7)

Company: https://www.keypedia.com/companies/marek-smilowski/10295795-a8df-432e-bc23-7cb9fe4a3db8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c